Figure 4.
Kaplan-Meier analysis of RFS in HLA-A*2402 matched and unmatched stage IIIb CRC groups. The HLA-A*2402 matched stage IIIb group had a nonsignificant trend toward better survival. RFS, relapse-free survival; HLA-A, human leukocyte antigen-A; HR, hazard ratio; CI, confidence interval; CRC, colorectal cancer.